The Regulatory Imperative for a Peptide Characterization CRO Deliverables Checklist A peptide characterization CRO deliverables checklist serves as a fundamental […]
Introduction: Biosimilar development is one of the most scientifically rigorous and regulatory-intensive processes in modern pharmaceutical science — and navigating
What is Biosimilar Development? A Step-by-Step Guide from Molecule to Market Read More »
Introduction to Encapsulating Hydrophilic vs Hydrophobic APIs in PLGA The development of clinically successful long-acting parenteral formulations depends on aligning
Encapsulating Hydrophilic vs Hydrophobic APIs in PLGA: Key Formulation Differences Read More »
Assessing the chemical safety of human drug products requires a thorough understanding of potential mutagenic and carcinogenic impurities that fall
Navigating Clinical Translation of CNS Small Molecules Under FDA Fast Track The clinical translation of central nervous system (CNS)-active small
Introduction: In peptide drug development, the quality of your analytical data is only as good as the reference standard anchoring
Identifying and addressing the root causes of failed Extractables and Leachables (E&L) studies has become a critical regulatory requirement for
Introduction Burst release in PLGA formulations is one of the most clinically consequential — and analytically challenging — phenomena in
Understanding Burst Release in PLGA Formulations — Causes, Consequences, and Mitigation Read More »
Introduction: When a nitrosamine exceeds the acceptable intake limit in a drug product or active pharmaceutical ingredient (API), it triggers
Introduction: Patient safety begins long before a drug product reaches the clinic — it begins with the container that holds
Extractables and Leachables (E&L) Testing for Container Closure Integrity Programs Read More »
